Proteasome Inhibitor News and Research

RSS
Takeda presents clinical study results of oral proteasome inhibitor MLN9708 in multiple myeloma patients

Takeda presents clinical study results of oral proteasome inhibitor MLN9708 in multiple myeloma patients

Acetylon announces positive preclinical data of ricolinostat (ACY-1215) in models of lymphoma

Acetylon announces positive preclinical data of ricolinostat (ACY-1215) in models of lymphoma

CRAB CTC enrolls first patient into inaugural cancer clinical trial

CRAB CTC enrolls first patient into inaugural cancer clinical trial

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Acetylon Pharmaceuticals presents positive interim data from two ricolinostat clinical trials at ASH 2013

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell transplants

Bortezomib reduces GVHD, boosts survival for patients receiving stem-cell transplants

Patrys initiates IST of PAT-SM6 in combination with carfilzomib in multiple myeloma patients

Patrys initiates IST of PAT-SM6 in combination with carfilzomib in multiple myeloma patients

Researchers find novel drug target for anaplastic thyroid carcinomas

Researchers find novel drug target for anaplastic thyroid carcinomas

Researchers discover why multiple myeloma recurs after initially effective treatment

Researchers discover why multiple myeloma recurs after initially effective treatment

Researchers discover why multiple myeloma persistently escapes cure

Researchers discover why multiple myeloma persistently escapes cure

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients

Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients

Researchers identify how proteasome takes care of unwanted, potentially toxic proteins

Researchers identify how proteasome takes care of unwanted, potentially toxic proteins

TIR-199 shows promise in fighting renal cancer

TIR-199 shows promise in fighting renal cancer

Novel testing reaction based on magnetic resonance data

Novel testing reaction based on magnetic resonance data

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Acetylon's ective histone deacetylase inhibitors to be showcased at 54th ASH annual meeting

Multi-center clinical trial results demonstrate safety and efficacy of carfilzomib for multiple myeloma

Multi-center clinical trial results demonstrate safety and efficacy of carfilzomib for multiple myeloma

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

FDA grants accelerated approval for Kyprolis to treat multiple myeloma

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

FDA grants accelerated approval to Onyx's Kyprolis for treatment of multiple myeloma

Onyx commences ENDEAVOR Kyprolis Phase 3 trial for relapsed multiple myeloma

Onyx commences ENDEAVOR Kyprolis Phase 3 trial for relapsed multiple myeloma

WCMC researchers devise innovative boxer-like strategy to fight multiple myeloma

WCMC researchers devise innovative boxer-like strategy to fight multiple myeloma